Q1 2024
Released May 7, 2024, after the close
10-Q filed May 7, 2024, 37 days after period end · 0001562762-24-000126
Q1 2024 · 10-Q
Revenue$606.67M$606.67M +119.3% vs Q1 2023−1.6% vs Q4 2023
Net Income-$7.12M-$7.12M N/M vs Q1 2023N/M vs Q4 2023
EPS Diluted-$0.05-$0.05 N/M vs Q1 2023no prior Q4 2023 on file
Gross Profit$365,179,000+77.4%
Operating Income$7,997,000−85.8%
Operating Cash Flow$52,387,000−1.7%
Free Cash Flowderived$23,819,000−36.2%
Margins · derived
Gross margin60.2%−14.2 pt vs Q1 2023
Operating margin1.3%−19.1 pt vs Q1 2023
Net margin-1.2%−18.9 pt vs Q1 2023
What the release said
The release
Same quarter
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $606.67M | $276.69M | $230.55M | $227.34M |
| Net Income | -$7.12M | $49.13M | $38.08M | $45.33M |
| EPS Diluted | -$0.05 | $0.48 | $0.37 | $0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR